The Moody Brain Health Institute (MBHI) will be the world’s leader in developing innovative approaches to solving disorders related to the human brain and nervous system. From pre-conception to death, the MBHI will address the unanswered questions that lead to innovative techniques and therapies to allow all to live with optimal brain functioning.
To foster the most innovative translational research endeavors that will receive ample national and international recognition.
To promote daring approaches to solve the most challenging disorders of the human nervous system.
To be the cradle for outstanding training of graduate students, postdocs and clinical fellows in the most advanced biomedical neurosciences.
To become the nation academic leader for brain health, healing and recovery.
The MBHI is a foundation platform where excellence in basic neuroscience synergizes with correspondent clinical endeavors to promote brain health, healing and recovery. Seeking life-changing discoveries, MBHI investigative teams will form to address fundamental unanswered questions to provide health and healing for the most debilitating illnesses, including Alzheimer’s Disease and related disorders, chronic pain, diseases of dependency, mental health disorders, neurological trauma, stroke, rehabilitation post neurologic insult, neurologic consequences of common diseases, such as Type 2 Diabetes, viral infections, long COVID-19 and cancer.
The MBHI is key to offering critical resources and unique services to the UTMB biomedical neuroscience community that are currently not available, including targeted grant development support, new core facilities and pilot project grants, to develop new, multi-disciplinary teams successfully attracting new NIH funding.
The MBHI will brand UTMB as the recognized leader in brain health by setting the highest standards of neuroscience healthcare, driven by the most rigorous and innovative basic and clinical research.
Patients from all over the country and the world will seek care at UTMB, confident they will receive the latest and most innovative therapies for their needs, including entering the most advanced clinical trials.